| Identification | Back Directory | [Name]
Methanone, (1'-ethyl-2,5,6,7-tetrahydrospiro[3H-furo[2,3-f]indole-3,4'-piperidin]-5-yl)[2'-methyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)[1,1'-biphenyl]-4-yl]- | [CAS]
180083-49-2 | [Synonyms]
SB236057
SB-236057
SB 236057
Methanone, (1'-ethyl-2,5,6,7-tetrahydrospiro[3H-furo[2,3-f]indole-3,4'-piperidin]-5-yl)[2'-methyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)[1,1'-biphenyl]-4-yl]- | [Molecular Formula]
C33H34N4O3 | [MOL File]
180083-49-2.mol | [Molecular Weight]
534.65 |
| Hazard Information | Back Directory | [Uses]
SB-236057 is an inverse agonist of the 5-HT1B receptor that exhibits strong skeletal teratogenicity in rodents and rabbits. SB-236057 affects gene expression during embryonic development through interference with the Notch signaling pathway and interaction with r-esp1. SB-236057 induces somatic patterning and tail extension defects in rat embryos during early organogenesis[1]. | [References]
[1] Augustine‐Rauch K A, et al. Evidence for a molecular mechanism of teratogenicity of SB‐236057, a 5‐HT1B receptor inverse agonist that alters axial formation[J]. Birth Defects Research Part A: Clinical and Molecular Teratology, 2004, 70(10): 789-807. DOI:10.1002/bdra.20076 |
|
|